Pro Medicus (ASX:PME) Insider Anthony Glenning Buys 2,080 Shares

Pro Medicus Limited (ASX:PME) insider Anthony Glenning acquired 2,080 shares of the firm’s stock in a transaction that occurred on Friday, February 13th. The shares were bought at an average price of A$119.81 per share, with a total value of A$249,204.80.

Pro Medicus Price Performance

The company has a current ratio of 5.98, a quick ratio of 4.39 and a debt-to-equity ratio of 1.10. The company has a market cap of $29.16 billion, a price-to-earnings ratio of 351.99, a PEG ratio of 3.87 and a beta of 0.56.

Pro Medicus Announces Dividend

The company also recently disclosed a Interim dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 19th will be paid a $0.32 dividend. The ex-dividend date is Wednesday, February 25th. This represents a yield of 27.0%. Pro Medicus’s dividend payout ratio is presently 56.41%.

About Pro Medicus

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.